Cleveland Clinic Journal of Medicine · May 1, 2026

Clonal hematopoiesis of indeterminate potential and heart disease: What every internist needs to know

By Oren O, Singh A, Carraway HE et al.

Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related condition defined by somatic mutations in hematopoietic stem cells that result in clonal expansion, without overt hematologic malignancy. It is now recognized as a potent risk factor for atherosclerotic cardiovascular disease, with emerging associations across a broader spectrum of cardiovascular phenotypes, including myocarditis, pericarditis, arrhythmias, valvular heart disease, and heart failure. The authors of this article review the epidemiology, pathophysiology, and management of this condition.

doi.org/10.3949/ccjm.93a.26003Open accessPubMed 42067232Mechanisms

AgingResearch.News